LYEL Lyell Immunopharma
- 2.250
- +0.080+3.69%
Lyell Immunopharma News
Lyell Immunopharma Sees Insider Stock Selling
Viewing insider transactions for Lyell Immunopharma, Inc.'s (NASDAQ:LYEL ) over the last year, we see that insiders were net sellers. This means that a larger number of shares were sold by insiders in
Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE:AGX) rose sharply during Friday's session as the company reported better-than-expected
CERS, GL and ATHE Are Among Pre Market Gainers
GLYC, APLD and AUTL Are Among After Hour Movers
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersOntrak (NASDAQ:OTRK) shares increased by 18.7% to $0.45 during Thursday's after-market session. The company's market cap stands at $18.9 million. Ocuphire Pharma (NASDAQ:OCUP) stock rose 7.82%
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Tilray Brands, Inc. (NASDAQ:TLRY) fell sharply during Tuesday's session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free cas
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday.
Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) Market Cap Decline of US$89m May Not Have as Much of an Impact on Institutional Owners After a Year of 1.4% Returns
Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) Institutional Investors Lost 8.6% Over the Past Week but Have Profited From Longer-term Gains
Key Insights Significantly high institutional ownership implies Lyell Immunopharma's stock price is sensitive to their trading actions 52% of the business is held by the top 6 shareholders Using d
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. Shares of Tesla, Inc. (NASDAQ:TSLA) fell during Monday's session after the company reportedly saw a decline in Fe
Express News | On Wednesday February 28, 2024, Lyell Immunopharma Reported Q4 Adjusted. EPS $(0.17) Beats $(0.23) Estimate, Sales $13.00K Down From $48.39M YoY
HC Wainwright & Co. Maintains Buy on Lyell Immunopharma, Lowers Price Target to $6
HC Wainwright & Co. analyst Mitchell Kapoor maintains Lyell Immunopharma (NASDAQ:LYEL) with a Buy and lowers the price target from $8 to $6.
Lyell Immunopharma Files $400M Mixed Securities Shelf
Press Release: Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023 -- On track to report initial clinical and translational data from lead CAR T-c
Lyell Immunopharma Announces Participation in March Investor Conferences
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (NASDAQ:LYEL), a clinical‐stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with
One Lyell Immunopharma Insider Has Reduced Their Stake
Insiders were net sellers of Lyell Immunopharma, Inc.'s (NASDAQ:LYEL ) stock during the past year. That is, insiders sold more stock than they bought. While we would never suggest that investors sh
Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (NASDAQ:LYEL), a clinical‐stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with
Companies Like Lyell Immunopharma (NASDAQ:LYEL) Are In A Position To Invest In Growth
After Losing 56% in the Past Year, Lyell Immunopharma, Inc. (NASDAQ:LYEL) Institutional Owners Must Be Relieved by the Recent Gain
Key Insights Institutions' substantial holdings in Lyell Immunopharma implies that they have significant influence over the company's share price 53% of the business is held by the top 6 shareholder
12 Health Care Stocks Moving In Friday's Intraday Session
GainersINVO Bioscience (NASDAQ:INVO) stock increased by 115.4% to $1.48 during Friday's regular session. As of 12:31 EST, INVO Bioscience's stock is trading at a volume of 63.2 million, which is 3488.
Analysis
Price Target
No Data
